We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01439750
Recruitment Status : Active, not recruiting
First Posted : September 23, 2011
Last Update Posted : August 7, 2017
Information provided by (Responsible Party):
Jeffrey J. Pu, MD, PhD, Milton S. Hershey Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : August 2018
  Estimated Study Completion Date : August 2020